Genentech, a leading biotechnology company, recently announced a workforce reduction at its South San Francisco headquarters. This marks the second round of layoffs at the Roche subsidiary in as many months, with 87 employees being affected. The decision comes as Genentech continues to realign its priorities to better address patient needs and deliver innovative medicines.
This move follows a similar downsizing last month when 143 employees were let go. The company stated that periodic adjustments to its workforce are necessary to ensure optimal functionality across its various departments. The layoffs are scheduled to take effect on September 15, as outlined in a Worker Adjustment and Retraining Notification (WARN) Act notice. Genentech’s recent workforce changes are part of a broader strategy shift that has been unfolding over the past year.
Read more from biospace.com